Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium
Raphael Brandt, Thomas Sell, Mareen Lüthen, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

The Frequency of Ras Mutations in Cancer
Ian A. Prior, Fiona E. Hood, James L. Hartley
Cancer Research (2020) Vol. 80, Iss. 14, pp. 2969-2974
Open Access | Times Cited: 789
Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15
Huiyuan Zhu, Man Li, Dexi Bi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Mitogen‐activated protein kinase activity drives cell trajectories in colorectal cancer
Florian Uhlitz, Philip Bischoff, Stefan Peidli, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 10
Open Access | Times Cited: 87
The ERK mitogen-activated protein kinase signaling network: the final frontier in RAS signal transduction
Jennifer E. Klomp, Jeffrey A. Klomp, Channing J. Der
Biochemical Society Transactions (2021) Vol. 49, Iss. 1, pp. 253-267
Closed Access | Times Cited: 63
Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK/FOXO3a signaling pathway
Iva Potočnjak, Lidija Šimić, Ivana Gobin, et al.
Toxicology in Vitro (2020) Vol. 66, pp. 104852-104852
Closed Access | Times Cited: 58
Helicobacter pylori shows tropism to gastric differentiated pit cells dependent on urea chemotaxis
Carmen Aguilar, Mindaugas Paužuolis, Malvika Pompaiah, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 29
RAS‐targeted cancer therapy: Advances in drugging specific mutations
Cen Liu, Danyang Ye, Hongliu Yang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 18
A guide to ERK dynamics, part 1: mechanisms and models
Abhineet Ram, Devan Murphy, Nicholaus DeCuzzi, et al.
Biochemical Journal (2023) Vol. 480, Iss. 23, pp. 1887-1907
Open Access | Times Cited: 17
Nuclear localization and actions of the insulin-like growth factor 1 (IGF-1) system components: Transcriptional regulation and DNA damage response
Elżbieta Poręba, Julia Durzyńska
Mutation Research/Reviews in Mutation Research (2020) Vol. 784, pp. 108307-108307
Open Access | Times Cited: 49
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
Taryn E. Gillies, Michael Pargett, Jillian M. Silva, et al.
Molecular Systems Biology (2020) Vol. 16, Iss. 10
Open Access | Times Cited: 46
Personalized signaling models for personalized treatments
Julio Sáez-Rodríguez, Nils Blüthgen
Molecular Systems Biology (2020) Vol. 16, Iss. 1
Open Access | Times Cited: 45
An Integrated Strategy for Mass Spectrometry-Based Multiomics Analysis of Single Cells
Yuanyuan Li, Hang Li, Yuping Xie, et al.
Analytical Chemistry (2021) Vol. 93, Iss. 42, pp. 14059-14067
Closed Access | Times Cited: 40
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer
Gian Marco Leone, Saverio Candido, Alessandro Lavoro, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1252-1252
Open Access | Times Cited: 14
Ku70 senses cytosolic DNA and assembles a tumor-suppressive signalosome
Abhimanu Pandey, Cheng Shen, Shouya Feng, et al.
Science Advances (2024) Vol. 10, Iss. 4
Open Access | Times Cited: 5
FGF Signalling in the Self-Renewal of Colon Cancer Organoids
Jörg Otte, Levent Dizdar, Bianca Behrens, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 42
Hexokinase 2 Promotes Cell Growth and Tumor Formation Through the Raf/MEK/ERK Signaling Pathway in Cervical Cancer
Nan Cui, Lu Li, Qian Feng, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 35
Modeling cancer metastasis using acoustically bio-printed patient-derived 3D tumor microtissues
Hui Chen, Liang Du, Juan Li, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 11, pp. 1843-1852
Closed Access | Times Cited: 20
High-dimensional signalling analysis of organoids
Aurélie Dobric, Christopher J. Tape
Current Opinion in Cell Biology (2025) Vol. 94, pp. 102488-102488
Open Access
Tumor‐Selective Gene Therapy: Using Hairpin DNA Oligonucleotides to Trigger Cleavage of Target RNA by Endogenous flap endonuclease 1 (FEN 1) Highly Expressed in Tumor Cells
Chunlu Wang, Chen Wang, Chijie Xiao, et al.
Small (2025)
Closed Access
Blocking PSMD14-mediated E2F1/ERK/AKT signaling pathways suppresses the progression of anaplastic thyroid cancer
Yuxuan Wang, Yuansheng Duan, Kai Yue, et al.
Cellular Signalling (2025), pp. 111826-111826
Closed Access
SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells
Kathleen Klotz‐Noack, Bertram Klinger, Maria Rivera, et al.
Cell Reports (2020) Vol. 32, Iss. 12, pp. 108184-108184
Open Access | Times Cited: 32
Lnc-FAM84B-4 acts as an oncogenic lncRNA by interacting with protein hnRNPK to restrain MAPK phosphatases-DUSP1 expression
Wen Peng, Chuan Zhang, Jianing Peng, et al.
Cancer Letters (2020) Vol. 494, pp. 94-106
Closed Access | Times Cited: 30
BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation
Nadine Reischmann, Geoffroy Andrieux, Ricarda Griffin, et al.
Oncogene (2020) Vol. 39, Iss. 38, pp. 6053-6070
Open Access | Times Cited: 28
Cytokine combinations for human blood stem cell expansion induce cell-type– and cytokine-specific signaling dynamics
Weijia Wang, Yang Zhang, Philip Dettinger, et al.
Blood (2021) Vol. 138, Iss. 10, pp. 847-857
Open Access | Times Cited: 27
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo
Arafath K. Najumudeen, Sigrid K. Fey, Laura M. Millett, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top